A mad scramble to stock millions of malaria pills, likely for nothing

New York Times

16 June 2020 - Before the F.D.A. withdrew its waiver to stockpile the drugs as coronavirus treatments, the Trump administration had embarked on a headlong effort to import tens of millions of doses.

The Food and Drug Administration’s abrupt decision this week to revoke an emergency waiver for two malaria drugs promoted by President Trump as potential “game changers” against the coronavirus has left 66 million doses stranded in the federal stockpile — and officials do not yet know what they will do with them.

Read New York Times article

Michael Wonder

Posted by:

Michael Wonder

Posted in:

US , Medicare , Supply , COVID-19